Patents by Inventor Laurence Corash

Laurence Corash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYOPRECIPITATE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
    Publication number: 20210260114
    Abstract: Provided herein are compositions and kits including a pathogen-inactivated cryoprecipitate suitable for infusion into a subject at least 1 day after thawing. The methods are useful in the efficient preparation of cryoprecipitates with desirable characteristics, including pathogen-inactivated cryoprecipitates that are suitable for infusion into a subject at least 1 day after thawing.
    Type: Application
    Filed: March 18, 2021
    Publication date: August 26, 2021
    Inventors: Laurence CORASH, Elan WEINER, Melody HOLTAN, Richard BENJAMIN
  • Cryoprecipitate compositions and methods of preparation thereof
    Patent number: 11096963
    Abstract: Provided herein are compositions and kits including a pathogen-inactivated cryoprecipitate suitable for infusion into a subject at least 1 day after thawing. The methods are useful in the efficient preparation of cryoprecipitates with desirable characteristics, including pathogen-inactivated cryoprecipitates that are suitable for infusion into a subject at least 1 day after thawing.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: August 24, 2021
    Assignee: Cerus Corporation
    Inventors: Laurence Corash, Elan Weiner, Melody Holtan, Richard Benjamin
  • PLASMA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210187020
    Abstract: Provided herein are pathogen-inactivated plasma compositions and methods for treating a disease or condition using pathogen-inactivated plasma compositions.
    Type: Application
    Filed: September 3, 2020
    Publication date: June 24, 2021
    Inventors: Laurence CORASH, Richard BENJAMIN, Elan WEINER
  • Plasma compositions and methods of use thereof
    Patent number: 10799533
    Abstract: Provided herein are pathogen-inactivated plasma compositions and methods for treating a disease or condition using pathogen-inactivated plasma compositions.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 13, 2020
    Assignee: Cerus Corporation
    Inventors: Laurence Corash, Richard Benjamin, Johannes Vermeij, Elan Weiner
  • PLASMA COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20180318348
    Abstract: Provided herein are pathogen-inactivated plasma compositions and methods for treating a disease or condition using pathogen-inactivated plasma compositions.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 8, 2018
    Inventors: Laurence CORASH, Richard BENJAMIN, Johannes VERMEIJ
  • COMPOSITIONS AND METHODS FOR TREATING VIRAL HEMORRHAGIC FEVER
    Publication number: 20170304363
    Abstract: The present disclosure provides compositions and methods for the treatment of viral hemorrhagic fever. The compositions and methods are useful for treating hemorrhagic fever virus infections and conditions associated with such infections.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Inventor: Laurence CORASH
  • CRYOPRECIPITATE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
    Publication number: 20170027986
    Abstract: Provided herein are compositions and kits including a pathogen-inactivated cryoprecipitate suitable for infusion into a subject at least 1 day after thawing. The methods are useful in the efficient preparation of cryoprecipitates with desirable characteristics, including pathogen-inactivated cryoprecipitates that are suitable for infusion into a subject at least 1 day after thawing.
    Type: Application
    Filed: June 24, 2016
    Publication date: February 2, 2017
    Inventors: Laurence CORASH, Elan WEINER, Melody HOLTAN, Richard BENJAMIN
  • Synthetic platelet storage media formulation
    Patent number: 6866992
    Abstract: Synthetic platelet storage media is disclosed for use with blood preparations intended for in vivo use. The synthetic platelet storage media is prepared by providing sodium chloride, sodium citrate, sodium acetate and sodium phosphate, and formulating in water 45-120 mM sodium chloride, 5-15 mM sodium citrate, 20-40 mM sodium acetate and 20-30 mM sodium phosphate.
    Type: Grant
    Filed: April 14, 2003
    Date of Patent: March 15, 2005
    Assignees: Baxter International Inc., Cerus Corporation
    Inventors: Lily Lin, Laurence Corash, Jean Marc Payrat
  • Synthetic media for blood components
    Publication number: 20030194806
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including synthetic media formulations to be employed in conjunction with the photodecontamination of platelets.
    Type: Application
    Filed: April 14, 2003
    Publication date: October 16, 2003
    Inventors: Lily Lin, Laurence Corash, Marc Payrat
  • Synthetic media for blood components
    Patent number: 6566046
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including synthetic media formulations to be employed in conjunction with the photodecontamination of platelets.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: May 20, 2003
    Assignees: Baxter International Inc., Cerus Corporation
    Inventors: Lily Lin, Laurence Corash, Marc Payrat
  • Synthetic media for blood components
    Publication number: 20010008757
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including synthetic media formulations to be employed in conjunction with the photodecontamination of platelets.
    Type: Application
    Filed: December 7, 2000
    Publication date: July 19, 2001
    Inventors: Lily Lin, Laurence Corash, Marc Payrat
  • Synthetic media for blood components
    Patent number: 6251580
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including synthetic media formulations to be employed in conjunction with the photodecontamination of platelets.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: June 26, 2001
    Inventors: Lily Lin, Laurence Corash, Jean Marc Payrat
  • Methods of photodecontamination using synthetic media
    Patent number: 5965349
    Abstract: Methods of photodecontamination are described which employ phosphate buffered aqueous solutions. Blood products comprising plasma are diluted with these solutions and treated with psoralen.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: October 12, 1999
    Assignee: Cerus Corporation
    Inventors: Lily Lin, Laurence Corash
  • Synthetic media for blood components
    Patent number: 5908742
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including essentially magnesium free synthetic media formulations to be employed in conjunction with the photodecontamination of platelets.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: June 1, 1999
    Assignee: Cerus Corporation
    Inventors: Lily Lin, Laurence Corash, Jean Marc Payrat
  • Proralen inactivation of microorganisms and psoralen removal
    Patent number: 5709991
    Abstract: Methods are disclosed for photodecontamination to inactivate microorganisms in platelet preparations and for removal of psoralen after photodecontamination. Removal is achieved by contacting the psoralen with a psoralen-binding polymer.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 20, 1998
    Assignee: Cerus Corporation
    Inventors: Lily Lin, Laurence Corash, John Tessman, George D. Cimino, Stephen T. Isaacs
  • Intravenous administration of psoralen
    Patent number: 5618662
    Abstract: Intravenous administration of 8-methoxypsoralen is disclosed, and more specifically intravenous administration of 8-methoxypsoralen-blood preparations, including platelets. Random donor platelet bags are treated, stored and pooled prior to transfusion.
    Type: Grant
    Filed: January 21, 1994
    Date of Patent: April 8, 1997
    Assignee: Cerus Corporation
    Inventors: Lily Lin, Laurence Corash
  • Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
    Patent number: 5459030
    Abstract: Synthetic media formulations are disclosed for use with blood preparations intended for in vivo use, including synthetic media formulations to be employed in conjunction with the photodecontamination of platelets using 8-methoxypsoralen.
    Type: Grant
    Filed: June 2, 1993
    Date of Patent: October 17, 1995
    Assignee: Steritech, Inc.
    Inventors: Lily Lin, Laurence Corash
  • Method of blood component decontamination by glucose addition
    Patent number: 5176921
    Abstract: Biological compositions are freed of functional polynucletides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive. More specifically blood components are decontaminated of viruses by the addition of psoralen and irradiation and thereafter adding glucose.
    Type: Grant
    Filed: May 11, 1989
    Date of Patent: January 5, 1993
    Assignees: Diamond Scientific Co., University of California
    Inventors: Gary P. Wiesehahn, Laurence Corash